科研项目：
1、国家“万人计划”青年拔尖人才项目，中西医结合防治呼吸道病毒感染研究，主持；
2、国家重点研发计划子课题，基于宿主与病毒交互作用解析的经典名方治疗新冠肺炎作用模式研究，主持；
3、国家自然科学基金面上项目，基于TGF-β-SP2-BRD7信号轴调控巨噬细胞糖酵解重编程探讨连翘苷治疗病毒性肺损伤机制，主持；
4、国家自然科学基金青年项目，基于NF-κB/POU2F2-PLCβ2通路的六神丸抑制新型冠状病毒所致炎症的作用机制研究，主持；
5、国家中医药多学科交叉创新团队项目子课题，基于邪毒袭肺理论创建“细胞-类器官-动物”一体化模型体系及抗病毒药效机制研究，主持；
代表性学术论文：
1、Qinhai Ma#, et al., Elucidating Forsythin’s Anti-Inflammatory Action Through Modulation of the P38 MAPK Pathway in SARS-CoV-2 Infection. Engineering, 54 (2025):187–201.
2、Qinhai Ma#, et al., Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway. Pharmacological Research, 2020, 8(158) :104850.
3、Qinhai Ma#, et al., Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway. Phytomedicine, 2020, 78:153296.
4、Zhu Li#, ... Qinhai Ma*, et al., Targeting FTO/m6A epigenetics: Phillyrin dual-blocks respiratory syncytial virus replication and inflammation via NF-κB/STAT3 silencing. Phytomedicine,2026,151(2026):157803
5、Chen Hua#, Qinhai Ma#, et al. Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation. Signal Transduct Target Ther.2021; 6(1):318.
6、Liling Yang#, ... Qinhai Ma*, et al., PEBL, a component-based Chinese medicine, reduces virus-induced acute lung injury by targeting FXR to decrease ACE2 levels. Journal of Advanced Research, 2026, 80:1099-1119.
获奖及个人荣誉：
1、国家“万人计划”青年拔尖人才
2、广东省科技厅“特支计划”青年拔尖人才
3、中国科协青年人才托举工程
4、广东省生物医药健康促进会科学技术奖创新成果奖一等奖
联系方式：
Email: 13268268214@163.com
吕嘉春
